chlorpromazine has been researched along with furosemide in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (36.07) | 18.7374 |
1990's | 1 (1.64) | 18.2507 |
2000's | 14 (22.95) | 29.6817 |
2010's | 23 (37.70) | 24.3611 |
2020's | 1 (1.64) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Topliss, JG; Yoshida, F | 1 |
Faller, B; Wohnsland, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Caron, G; Ermondi, G | 1 |
Cohen, FE; Legname, G; May, BC; Prusiner, SB; Sherrill, J; Wallace, AC; Witkop, J; Zorn, JA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Goetz, GH; Philippe, L; Shapiro, MJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Bojarski, AJ; Dehaen, W; Janousek, J; Juza, R; Karasova, JZ; Kobrlova, T; Korabecny, J; Kubacka, M; Mezeiova, E; Mogilski, S; Musilek, K; Pejchal, J; Petrasek, T; Prchal, L; Randakova, A; Satala, G; Soukup, O; Stark, H; Stefkova-Mazochova, K; Svozil, D; Vlcek, P; Vojtechova, I | 1 |
Petritsch, PH | 2 |
Boyer, D; Collins, GM; Green, RD; Halasz, NA | 1 |
Biglioli, P; Gherli, T; Martello, L; Roma, G | 1 |
Grenroth, C; Norée, LO; Söder, G; Wiklund, PE | 1 |
Concha, J; Contreras, G; González, C; Norris, B; Palacios, S | 1 |
Baldew, GS; de Goeij, JJ; de Vries, M; McVie, JG; Vernie, LN; Zegers, C | 1 |
Chikanza, IC; Okwanga, PN | 1 |
Guerrant, RL; Weikel, CS | 1 |
Lawson, AA; Nimmo, GR | 1 |
Askari, A; Rao, SN | 1 |
Bell, PR; Calman, KC; Quin, RO | 1 |
Humphries, AL; Liu, WP | 1 |
Masters, AB | 1 |
Gullo, A; Romano, E | 1 |
Moore, DE; Tamat, SR | 1 |
Berlot, G; Fasiolo, S; Gullo, A; Romano, E; Vacri, A | 1 |
Hilden, T; Krogsgaard, A; McNair, A; Nielsen, PE | 1 |
Halawa, B | 1 |
Lawson, AA; Malone, DN; Young, RJ | 1 |
Amaral, CF; Cardini, JF; da Silva, OA; da Silveira, JC; de Oliveira, JS; Fonseca, JG; Lopes, JA; López, M | 1 |
Chernysh, AM; Kozlova, EK; Kuzovlev, AN; Moroz, VV | 1 |
4 review(s) available for chlorpromazine and furosemide
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Perfusates for preservation of kidneys, livers and hearts.
Topics: Animals; Blood; Chlorpromazine; Dogs; Electrolytes; Furosemide; Heart Transplantation; Heparin; Humans; In Vitro Techniques; Intracellular Fluid; Kidney Transplantation; Liver Transplantation; Mannitol; Organ Preservation; Perfusion; Plasma; Serum Albumin; Solutions; Steroids; Swine; Tissue Preservation; Transplantation, Homologous | 1974 |
[Treatment of arterial hypertension in elderly patients].
Topics: Age Factors; Aged; Antihypertensive Agents; Chlorpromazine; Diazoxide; Dihydralazine; Drug Therapy, Combination; Furosemide; Humans; Hydrochlorothiazide; Hypertension; Methyldopa; Middle Aged; Spironolactone | 1981 |
3 trial(s) available for chlorpromazine and furosemide
Article | Year |
---|---|
Cerebral symptoms and blood pressure during parenteral administration of chlorpromazine, dihydralazine and diazoxide. Danish multicenter study on acute severe hypertension.
Topics: Blood Pressure; Brain Diseases; Brain Ischemia; Chlorpromazine; Clinical Trials as Topic; Diazoxide; Dihydralazine; Emergencies; Furosemide; Humans; Hydralazine; Hypertension; Hypotension; Paralysis; Risk | 1983 |
[Treatment of acute, severe hypertension assessed in a multicentre study. The effects of rest and furosemide and a randomized clinical trial of chlorpromazine, dihydralazine and diazoxide].
Topics: Adult; Aged; Bed Rest; Chlorpromazine; Clinical Trials as Topic; Diazoxide; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1981 |
Emergency treatment of severe hypertension evaluated in a randomized study. Effect of rest and furosemide and a randomized evaluation of chlorpromazine, dihydralazine and diazoxide. Danish Multicenter Study.
Topics: Adult; Aged; Chlorpromazine; Denmark; Diazoxide; Dihydralazine; Drug Administration Schedule; Female; Furosemide; Humans; Hydralazine; Hypertension; Male; Middle Aged; Posture; Prospective Studies; Random Allocation | 1980 |
54 other study(ies) available for chlorpromazine and furosemide
Article | Year |
---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Structure-activity relationship study of prion inhibition by 2-aminopyridine-3,5-dicarbonitrile-based compounds: parallel synthesis, bioactivity, and in vitro pharmacokinetics.
Topics: Aminopyridines; Animals; Cell Line, Tumor; Combinatorial Chemistry Techniques; Membranes, Artificial; Mice; Models, Molecular; Nitriles; Permeability; PrPSc Proteins; Solubility; Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic Peptides.
Topics: | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Novel D
Topics: Animals; Antipsychotic Agents; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Schizophrenia | 2022 |
[Pathophysiology of kidney lesions after temporary ischemia and measures for their prevention].
Topics: Animals; Chlorpromazine; Creatinine; Dogs; Edema; Electrolytes; Furosemide; Heparin; Hypothermia; Ischemia; Kidney; Kidney Tubules; Mannitol; Organ Preservation; Osmolar Concentration; Perfusion; Rabbits | 1979 |
Pharmacological protection of rabbit kidneys from normothermic ischemia.
Topics: Animals; Body Temperature; Chlorpromazine; Dopamine; Female; Furosemide; Ischemia; Kidney; Male; Mannitol; Methylprednisolone; Phenoxybenzamine; Propranolol; Rabbits | 1979 |
[Behavior of the aorto-carotid receptors after partial and total substitution of the thoracic aorta. Considerations on resuscitation].
Topics: Adult; Aorta, Thoracic; Aortic Aneurysm; Aortic Dissection; Blood Vessel Prosthesis; Carotid Sinus; Chlorpromazine; Dopamine; Epinephrine; Furosemide; Humans; Imidazoles; Middle Aged; Pressoreceptors; Promethazine; Trimethaphan | 1978 |
[Pathophysiological damage to the kidney due to temporary ischemia and measures to avoid these changes (author's transl)].
Topics: Animals; Chlorpromazine; Creatinine; Dogs; Female; Furosemide; Heparin; Ischemia; Kidney; Kidney Transplantation; Male; Mannitol; Organ Preservation; Tissue Preservation; Transplantation, Homologous | 1976 |
Treatment of pre-eclampsia and eclampsia as a hypoperfusion syndrome.
Topics: Acidosis; Adult; Albumins; Blood Pressure; Chlorpromazine; Eclampsia; Edema; Female; Furosemide; Glucose; Humans; Hypotension; Mannitol; Oxygen; Plasma Substitutes; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Regional Blood Flow; Syndrome; Vascular Resistance | 1975 |
Stimulatory effect of angiotensin II on electrolyte transport in canine tracheal epithelium.
Topics: Angiotensin II; Animals; Chlorides; Chlorpromazine; Dogs; Electrolytes; Epithelium; Female; Furosemide; In Vitro Techniques; Indomethacin; Male; Mucous Membrane; Muscle, Smooth; Trachea | 1991 |
Cisplatin-induced changes of selenium levels and glutathione peroxidase activities in blood of testis tumor patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorpromazine; Cisplatin; Dysgerminoma; Furosemide; Glutathione Peroxidase; Hematocrit; Humans; Male; Mannitol; Middle Aged; Neoplasm Proteins; Selenium; Teratoma; Testicular Neoplasms; Vinblastine | 1988 |
Chlorpromazine and frusemide in the acute management of severe hypertension.
Topics: Acute Disease; Adult; Chlorpromazine; Emergencies; Female; Furosemide; Humans; Hypertension; Infusions, Parenteral; Male; Middle Aged | 1989 |
STb enterotoxin of Escherichia coli: cyclic nucleotide-independent secretion.
Topics: Animals; Bacterial Toxins; Calcium; Chlorides; Chlorpromazine; Cyclic AMP; Diarrhea; Electrolytes; Enterotoxins; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Furosemide; Humans; Intestinal Mucosa; Jejunum; Kinetics; Swine | 1985 |
Parenteral chlorpromazine and frusemide: safe and effective treatment for hypertensive emergencies.
Topics: Adult; Aged; Chlorpromazine; Creatinine; Drug Therapy, Combination; Emergencies; Female; Furosemide; Humans; Hypertension; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Urea | 1986 |
Drugs affecting sodium transport in human erythrocyte ghosts.
Topics: Acetates; Adenosine Triphosphatases; Anesthetics, Local; Biological Transport, Active; Cell Membrane; Chlorpromazine; Desipramine; Dipyridamole; Erythrocytes; Ethacrynic Acid; Furosemide; Humans; Imipramine; Iodine; Lactates; Oligomycins; Ouabain; Potassium; Pyruvates; Sodium | 1970 |
Donor pretreatment and organ preservation.
Topics: Animals; Chlorpromazine; Coronary Vessels; Furosemide; Heart Transplantation; Heparin; Ischemia; Kidney; Kidney Transplantation; Organ Preservation; Phenoxybenzamine; Rats; Tissue Donors; Tissue Preservation; Transplantation, Homologous | 1974 |
Delayed death in imipramine poisoning.
Topics: Chlorpromazine; Female; Furosemide; Gastric Lavage; Heart Arrest; Humans; Imipramine; Infusions, Parenteral; Mannitol; Middle Aged; Paraldehyde | 1967 |
Chlorpromazine and frusemide in treatment of acute left-ventricular failure.
Topics: Acute Disease; Aged; Blood Pressure; Carbon Dioxide; Chlorpromazine; Drug Therapy, Combination; Furosemide; Heart Failure; Heart Rate; Heart Ventricles; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Middle Aged; Pulmonary Edema; Respiration; Vasodilator Agents | 1980 |
Photosensitization by drugs: photolysis of some chlorine-containing drugs.
Topics: Chemistry, Pharmaceutical; Chlorine; Chlorpromazine; Furosemide; Humans; Hydrochlorothiazide; Oxidation-Reduction; Pharmaceutical Preparations; Photochemistry; Photosensitivity Disorders; Prochlorperazine; Spectrophotometry, Ultraviolet | 1980 |
[Medical therapy of acute cardiogenic pulmonary edema. Critical review].
Topics: Acute Disease; Blood Pressure; Chlorpromazine; Digitalis; Diuretics; Furosemide; Heart; Humans; Morphine; Nitroglycerin; Nitroprusside; Oxygen Inhalation Therapy; Plants, Medicinal; Plants, Toxic; Pulmonary Edema; Vasodilator Agents | 1984 |
Treatment of severe hypertension with chlorpromazine and frusemide.
Topics: Adult; Chlorpromazine; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Prospective Studies | 1980 |
[Treatment of low output syndrome in chronic Chagas cardiopathy].
Topics: Adolescent; Adult; Cardiac Output, Low; Chagas Cardiomyopathy; Chlorpromazine; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Norepinephrine | 1980 |
Analysis of nanostructure of red blood cells membranes by space Fourier transform of AFM images.
Topics: Adult; Cell Membrane; Cell Membrane Structures; Chlorpromazine; Erythrocytes; Fourier Analysis; Furosemide; Hemin; Humans; Microscopy, Atomic Force; Nanostructures; Zinc | 2013 |